Last reviewed · How we verify
NCT05245214
Muscle Analyze In Patient With Disc Herniation
trial testing Magnetic Resonance Imaging in Disk Herniated Lumbar in 330 participants. Completed in 7 January 2022.
1 January 2022
Quick facts
| Lead sponsor | Karamanoğlu Mehmetbey University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 330 |
| Start date | 2 March 2021 |
| Primary completion | 1 January 2022 |
| Estimated completion | 7 January 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Magnetic Resonance Imaging
Conditions studied
- Disk Herniated Lumbar — all drugs for Disk Herniated Lumbar →
Sponsor
Karamanoğlu Mehmetbey University
Who can join
Adults 20 to 70, any sex, with Disk Herniated Lumbar. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study which was planned to investigate the factors affecting m. erector spinae (ES), m. multifidus (MF), m. psoas major (PM) and m. quadratus lumborum (QL), which stabilize the lumbar region in the case of disc herniation. In this study, the effects of disc herniation, herniation severity, age, and spinal biomechanics were investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05245214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Magnetic Resonance Imaging
Trials testing the same drug.
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT07229339 — Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07441681 — Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive · Phase 3 · not yet recruiting
- NCT07147231 — Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cem · Phase 1, PHASE2 · recruiting
- NCT06448286 — PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glio · Phase 3 · not yet recruiting
Other Karamanoğlu Mehmetbey University trials
Trials by the same sponsor.
- NCT07499297 — THE EFFECTS OF CIRCADIAN RHYTHM-BASED PROGRESSIVE RELAXATION EXERCISES IN HEMODIALYSIS PATIENTS · NA · not yet recruiting
- NCT07406607 — The Effect of Presence of Father in the Operating Room on Quality of Recovery of the Parturient · NA · recruiting
- NCT07302282 — The Effectiveness of Pain Neuroscience Education for Patients With Carpal Tunnel Syndrome · NA · recruiting
- NCT07377851 — Carbonic Anhydrase II Responses to Basketball-Specific High-Intensity Interval Training · NA · completed
- NCT07142577 — The Effect of Mandala Coloring on Mental Well-Being and Life Satisfaction in Elderly Individuals in Nursing Homes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05245214 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karamanoğlu Mehmetbey University
- Last refreshed: 10 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05245214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing